1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow C2N Diagnostics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy Single dose C2N-8E12, Single dose placebo - Progressive Supranuclear Palsy | Phase 1 | Completed | C2N Diagnostics | 32 | 2015-07-01 | 2017-07-26 |
Supranuclear Palsy, Progressive (1) · Tauopathies (1)
United States (1)